The DNMT inhibitor SGI-1027, the safety of which was validated in a rat hepatoma (H4IIE) cell line, decreased methylation by inhibiting the activity of DNMT3B.41 This DNMT inhibitor might upregulate HOXB13 expression by decreasing methylation in cancer cells. This evidence concerns the gene HOXB13 and hepatocellular carcinoma.